The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors.
 
Jennifer Rachel Eads
Consulting or Advisory Role - Amgen; Exelixis; Merrimack
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); EMD Serono (Inst); HealthCare Pharmaceuticals (Inst); Merck (Inst); Symphony Evolution (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune (I)
 
Smitha S. Krishnamurthi
Research Funding - Celgene; CytomX Therapeutics; Nektar; Regeneron; Taiho Pharmaceutical
 
Joel N. Saltzman
Stock and Other Ownership Interests - novartis; Roche
Consulting or Advisory Role - Lilly; Lilly
 
David Lawrence Bajor
Research Funding - Apexigen; Roche/Genentech; Seagen; Tesaro
 
Shaveta Vinayak
Consulting or Advisory Role - Tesaro
 
Jill Barnholtz-Sloan
No Relationships to Disclose
 
Neal J. Meropol
Employment - Flatiron Health
Research Funding - Genomic Health
Patents, Royalties, Other Intellectual Property - US Patent (20020031515): Methods of therapy for cancers characterized by over expression of the HER2 receptor protein; US Patent Office “Systems and methods for matching patients with clinical trials.” (Cui, Mergler, Meropol, Tao, and Guo-Qiang Zhang). Patent pending, filed January 5, 2016. 14/988,132
Travel, Accommodations, Expenses - Flatiron Health
 
Sanford D. Markowitz
Employment - Rodeo Therapeutics
Leadership - Rodeo Therapeutics
Stock and Other Ownership Interests - Rodeo Therapeutics
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - GlaxoSmithKline; Rodeo Therapeutics
Research Funding - Rodeo Therapeutics
Patents, Royalties, Other Intellectual Property - Exact Sciences; Rodeo Therapeutics
 
Zhenghe Wang
Research Funding - Calithera Biosciences (Inst)